Navigation Links
Icahn Responds to Cornelius
Date:9/23/2008

atments designed to address the medical needs of patients with a variety of cancers. The Company's research and development programs include growth factor blockers and angiogenesis inhibitors. ImClone Systems' headquarters and research operations are located in New York City, with additional administration and manufacturing facilities in Branchburg, New Jersey. For more information about ImClone Systems, please visit the Company's web site at http://www.imclone.com.

Important Information about the Press Release

The tender offer referred to in this press release has not commenced and this press release is neither an offer to buy nor invitation to purchase any securities, or an offer to sell any securities. This does not constitute a recommendation as to any tender offer nor does this communication constitute a solicitation of any vote or approval.

Investors and security holders are urged to read any disclosure documents filed with the SEC including any tender offer statement and Imclone Systems' recommendation when it is available because they contain important information. Investors and security holders will be able to obtain a free copy of the disclosure documents and recommendation (when they are available) and other documents filed with the SEC at the SEC's website at http://www.sec.gov or from Imclone Systems at its office at 180 Varick Street, New York, NY 10014

Forward Looking Information

Certain matters discussed in this news release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions it can give no assurance that its expectations will be achieved. Forward-looking information is subject to certain ri
'/>"/>

SOURCE Carl Icahn
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Icahn Confirms Intention to Nominate Three Directors at Biogen
2. Protein Sciences Responds to Emergent BioSolutions Lawsuit
3. Neuftec Responds to a Fundamental Inaccuracy in Oxonica PLCs Regulatory Announcement
4. Neuralstem Responds to New StemCells, Inc. Lawsuit
5. AGA Medical Corporation Responds to Occlutech Statement on the Status of the Ongoing Patent Litigation in Europe
6. MichBio Responds to Governors Plan to Repeal Tort Reform Laws
7. CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases
8. Bio-Identical Hormone Menopause Doctor Responds to Recent FDA News About Estriol
9. Bio-Identical Hormone Menopause Doctor Responds to Outrageous FDA News
10. CryoLife Responds to Inaccurate Assertions from Plaintiffs Attorney
11. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/7/2015)... 2015 Kiadis   ... company developing innovative immunotherapy treatments, today announces the ... an independent member of its Supervisory Board. ... experience in the oncology and immunology field, including ... was Senior Vice-President and had responsibility for the ...
(Date:5/7/2015)... , May 7, 2015 ... pharmaceuticals company, today announces positive results from the ... hyperphosphataemia related to dialysis dependent chronic kidney disease ... by leading Cambridge -based scientists ... novel phosphate binder that is based on proprietary ...
(Date:5/6/2015)... , May 6, 2015 ... anzukündigen, dass das Unternehmen einen mehrjährigen Vertrag ... dem das Unternehmen exklusiv für den Vertrieb ... 2 S) konventionellen und organischen Wein- und ... tritt ab sofort in Kraft. ...
(Date:5/6/2015)... 6, 2015 Bone Biologics, Corp., ("Bone Biologics") announced ... Capital, LLC ("Hankey Capital") of Los Angeles, CA. ... use in bone regenerative medicine using the patented recombinant human ... undergoing spinal fusion. Michael Schuler , ... completion of this round of funding which will allow the ...
Breaking Biology Technology:Kiadis Pharma Appoints Dr. Vincent Brichard to its Supervisory Board 2Kiadis Pharma Appoints Dr. Vincent Brichard to its Supervisory Board 3Kiadis Pharma Appoints Dr. Vincent Brichard to its Supervisory Board 4Phosphate Therapeutics Announces Positive Results in the PEACH Pivotal Study of its Novel Phosphate Binder (PT20) for the Treatment of hyperphosphataemia 2Phosphate Therapeutics Announces Positive Results in the PEACH Pivotal Study of its Novel Phosphate Binder (PT20) for the Treatment of hyperphosphataemia 3Renaissance Yeast Inc. ernennt Quercus Europe, S.L. zum exklusiven Fachhändler für Schwefelwasserstoff-vermeidende Wein- und Mosthefen in Spanien 2Bone Biologics Corp Completes Financing With Hankey Capital, LLC 2Bone Biologics Corp Completes Financing With Hankey Capital, LLC 3
... SUNNYVALE, Calif., Sept. 14 Pharmacyclics, Inc. (Nasdaq: ... innovative small molecule drugs for the treatment of immune mediated ... results for the fourth quarter and fiscal year ended June ... 17, 2009 at 1:30 p.m. PDT (4:30 p.m. EDT). To ...
... , , JOHNSON CITY, Tenn., ... a potent radioprotectant as well as radiomitigator, protects against lethal, whole-body ... exposure. , , In recent experiments, the ... dose at either 48 or 72 hours after lethal, whole-body gamma ...
... , ... To achieve high levels of protein expression, many researchers have abandoned cloning in ... at a reasonable cost. Unlike a natural gene, a synthetic gene can be ... potential to be a huge advantage, as most researchers have come to accept ...
Cached Biology Technology:Pharmacyclics Announces Date of Fourth Quarter and Fiscal Year End 2009 Conference Call 2Rx100 Rescues Life if Administered Up to 72 Hours After Exposure to Lethal, Whole-Body Radiation! 2DNA2.0 Unlocks The Secrets Of Optimized Gene Design: Company Identifies Codon Choice Design Principles for Optimal Protein Expression 2DNA2.0 Unlocks The Secrets Of Optimized Gene Design: Company Identifies Codon Choice Design Principles for Optimal Protein Expression 3DNA2.0 Unlocks The Secrets Of Optimized Gene Design: Company Identifies Codon Choice Design Principles for Optimal Protein Expression 4
(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
(Date:5/6/2015)... AVIV, Israel , May 6, 2015 ... world,s most established helmet producer, announced today that they ... Smart Helmet, the world,s first bio-sensing cycling helmet and ... be released in two new colors in order to ... for the product. In addition, LifeBEAM and Lazer announced ...
(Date:5/5/2015)... May 5, 2015, NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, reminds investors and media ... Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held ... The three-day conference is organized into a ... in is themed Global Fraud: Where is the Trust ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
... Nine faculty members from The University of Texas at ... The University of Texas System Board of Regents for ... with a $25,000 cash award and recognize faculty members ... performance and innovation at the undergraduate level. The professors ...
... Schools of Medicine and Dentistry has received an award of ... Refinement and Reduction of Animals in Research (NC3Rs), for a ... of mouse cell which could be used in place of ... lung conditions. Macrophages are crucial components of the immune ...
... UCLA that conducts kidney tests and transmits data through ... frequent office visits by people with diabetes and others ... device was developed in the research lab of Aydogan ... the UCLA Henry Samueli School of Engineering and Applied ...
Cached Biology News:9 UT Arlington educators honored for teaching excellence 2Funding for animal testing alternative 2UCLA researchers invent portable device for common kidney tests 2
... Novel Object Records behavior directed toward examining ... line is a family of instruments all built ... extraction software and that can track two fields ... Software automatically extracts animal positions and records ...
... Magnetofection technology, SilenceMag is the most ... rapid and easy to use, SilenceMag ... Specifically designed for siRNA delivery, SilenceMag ... low doses of siRNA.,SilenceMag formulation gives ...
... technology, SilenceMag is the most efficient ... and easy to use, SilenceMag is ... designed for siRNA delivery, SilenceMag allows ... doses of siRNA.,SilenceMag formulation gives reliable ...
... O 2 S 2 Formula ... crystalline powder Assay: greater than or ... Melting Point: greater than or equal ... or equal to 1% Storage: ...
Biology Products: